RxDoctor Payments DataLook up a doctor →

Kenneth Jones, MD

Adult Medicine · Union City, GANPI 1417018920

Payments from drug & device makers

$8,727in general payments, 2019–2025

Across 530 payments — averaging $16.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • AstraZeneca$1K
  • Sanofi-aventis U.S. LLC$879
  • Novo Nordisk$735
  • Lilly USA, LLC$582
  • Boehringer Ingelheim$395
  • plus $4K from 43 others

What the payments were for

  • Food & beverage$8,64299%
  • Education$851%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,727 in reported general payments places this provider in the 85th percentile of 43 adult medicine providers in Georgia.

See all adult medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$42,962
Medicare patients
85
Services billed
514

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin103$69,235
OzempicSemaglutide45$50,565
MounjaroTirzepatide38$42,773
TrulicityDulaglutide31$38,535
Soliqua 100-33Insulin Glargine/Lixisenatide34$35,637
LinzessLinaclotide42$33,320
EliquisApixaban31$24,148
Breztri AerosphereBudesonide/Glycopyr/Formoterol26$18,740
Janumet XrSitagliptin Phos/Metformin Hcl22$17,719
RybelsusSemaglutide11$17,451
GlyxambiEmpagliflozin/Linagliptin15$17,136
FarxigaDapagliflozin Propanediol29$16,035
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$13,769
XareltoRivaroxaban11$12,539
JanuviaSitagliptin Phosphate21$9,549

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Glyxambi$395$86,371118 claims
Lilly USA, LLCMounjaro, Trulicity$582$81,30869 claims
Novo NordiskOzempic, Rybelsus$735$68,01656 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$879$35,63734 claims
AstraZenecaBreztri Aerosphere, Farxiga$1,018$34,77555 claims
AbbVieLinzess$1,061$33,32042 claims
MerckJanumet Xr, Januvia$157$27,26843 claims
PfizerEliquis$361$24,14831 claims
GSKTrelegy Ellipta$174$13,76913 claims
Johnson & JohnsonXarelto$50$12,53911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 43 adult medicine providers in Georgia.

Other adult medicine in Union City

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →